Cited by 713Multiple Sclerosis Research StudiesCancer survivorship and careAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis

Open access
Boeschoten, Rosa E., Braamse, Annemarie M.J., Beekman, Aartjan T.F., Cuijpers, Pim, van Oppen, Patricia, Dekker, Joost, Uitdehaag, Bernard M.J.·2017·Journal of the Neurological Sciences

Abstract

Objective Prevalence rates of depression and anxiety in patients with Multiple Sclerosis (MS) vary widely across studies. Aim of this systematic review and meta-analysis was to a) estimate the prevalence of depression and anxiety in MS, and specifically b) explore sources of heterogeneity (assessment method, prevalence period, study quality, recruitment resource, region) by extensive analyses.Methods A computerized search in PubMed, EMBASE, and PsycINFO for studies on depression and anxiety in MS was performed up to December 2014.Results Fifty-eight articles with a total sample size of 87,756 MS patients were selected. Pooled mean prevalence was 30.5% (95% CI=26.3%-35.1%) for depression, and 22.1% (95% CI=15.2%-31.0%) for anxiety. Prevalence of clinically significant depressive or anxiety symptoms was higher (35% and 34%) compared with disorders (21%; p=0.001 and 10%; p<0.001). Prevalence of a depressive disorder was relatively lower in studies from Europe. Anxiety disorder was more prevalent in community-based samples. Sources of high heterogeneity were not revealed.Conclusions Data of a large number of patients indicate increased prevalence of depression and anxiety in MS. Further research is needed to identify sources of heterogeneity. Issues to consider are the definition of depression and anxiety, patient recruitment, and patient characteristics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jns.2016.11.067

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The four common upper motor neuron disorders cause significant decline in physical function and often lead to secondary complications affecting quality of life, including cognitive impairment, fatigue, chronic pain, depression, and anxiety.

    “These 4 common UMNDs result in a significant decline in physical function5,7,8,17,18 and often develop secondary complications that affect their quality of life (QOL), including cognitive impairment,19–21 fatigue,22 chronic pain,23,24 depression,25–27 and anxiety.25–27”

    From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [26]

    The Introduction (page not provided) says depression and anxiety are common in multiple sclerosis and are related to lower quality of life. The citation is attached to depression and anxiety, not the other listed complications, but this paper does not establish that all four upper motor neuron disorders develop them or that the disorders cause them. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Physical health difficulties such as cancer, diabetes, and multiple sclerosis are highly comorbid with anxiety symptoms.

    “Previous meta-analyses have found strong evidence to suggest physical health difficulties such as cancer, diabetes, and multiple sclerosis are highly comorbid with anxiety symptoms (Nikbakhsh et al., 2014; Janzen Claude et al., 2014; Boeschoten et al., 2017).”

    From Do non-pharmacological sleep interventions affect anxiety symptoms? A meta-analysis (2022) · cites this paper as Boeschoten et al., 2017

  • Rates of emotional disorders are high among people with multiple sclerosis.

    “R ates of emotional disorders (EDs) are high among people with multiple sclerosis (MS). 1-4”
  • MS patients show increased levels of anxiety and depression compared to healthy participants, and these conditions affect more than 20% of patients.

    “MS patients show increased levels of anxiety and depression compared to healthy participants, and these conditions affect more than 20% of patients [8,21,22,23].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Boeschoten, R. E., Braamse, A. M. J., Beekman, A. T. F., Cuijpers, P., van Oppen, P., Dekker, J., & Uitdehaag, B. M. J.
Affiliations
  • Amsterdam Public Health (NL)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Corresponding author
Boeschoten, Rosa E.
Venue
Journal of the Neurological Sciences
Publisher
Elsevier BV
Published
2017-01
Volume
372
Pages
331-341
ISSN
0022-510X (ISSN-L)
OpenAlex
W2558115423
Cited by
713
References
125
Citations by year
2026: 87 · 2025: 70 · 2024: 83 · 2023: 100 · 2022: 92 · 2021: 110 · 2020: 89 · 2019: 40 · 2018: 32 · 2017: 9
FWCI
4.23
Type
journal article
Language
en
Open access
Locations
  • Journal of the Neurological Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Stichting MS Research (09-678)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
multiple sclerosis, depression, anxiety, prevalence, psychiatric comorbidity, depressive disorders, anxiety disorders, heterogeneity sources, community sample
MeSH terms
Anxiety, Depression, Humans, Multiple Sclerosis, Prevalence, Databases, Bibliographic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review